Clinical Trial Update: A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating weight loss with BGM0504 in overweight or obese Chinese adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• BGM0504

Snippet

Sponsor: BrightGene Bio-Medical Technology Co., Ltd. | Conditions: Overweight or Obesity | Phase 2 | Status: COMPLETED